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Purpose: Surgical outcome data are generally reported as raw morbidity and mortality 
rates, which do not necessarily reflect quality of surgical care. The Society for Vascular 
Surgery has led this area with recommendations by the Ad Hoc Committee on Reporting 
Standards to establish standardized methods of outcome assessment in vascular surgery. 
The purpose of this study was to evaluate a new method for evaluating the overall quality 
of surgical care, which includes urgeon, nursing, and hospital system performance. The 
goal of the method is to identify problem areas in surgical practice that can be targeted 
for focused improvement to improve outcome. 
Methods: A database of more than 9000 general and vascular surgical ses was compiled 
over a 3-year period. Every postoperative complication was tabulated prospectively by a 
surgical nurse on a daily basis. Fifty clinically significant complication types specific for 
vascular surgery patients were identified from a list of 151 postoperative events by a panel 
of vascular surgeons and were grouped into nine broad categories (vascular, cardiac, 
pulmonary, etc.). These complications reflect he entire continuum of postoperative care, 
including surgeon, nursing, and hospital system performance. Each complication type 
was further stratified into four grades (mild, moderate, severe, death) and assigned a
SCOUT severity score from 0 to 100 (0, no complication; 100, death) by the panel of 
surgeons. For ease of data collection and monitoring of outcome, a software program was 
developed to run on a laptop computer and includes medical history, risk factors, 
pertinent laboratory data, and the preassigned SCOUT severity scores for measuring 
outcome. In this study, 170 major vascular procedures performed over the previous 
12-month period were prospectively valuated using the SCOUT method in an attempt 
to more easily identify problem areas of practice. In-hospital morbidity and 30-day 
mortality results were examined. 
Results: One hundred sixteen postoperative complications were identified in the 170 
patients, with an overall morbidity rate of 51% and a 30-day mortality rate of 1.8%. 
Fifty-three percent of the complications were "mild" and required minimal intervention 
or observation only. Abdominal aortic aneurysm repair was associated with the highest 
morbidity rate (mean SCOUT score, 384.35), whereas distal extremity bypass grafting 
had the lowest morbidity rate (mean SCOUT score, 114.4). However, subgroup analysis 
demonstrated that cardiac events accounted for 52% of the morbidity associated with 
distal extremity bypass but only 34.7% of the morbidity associated with abdominal aortic 
aneurysm repair (p < 0.05). 
Conclusions: The SCOUT score is a new technical quality of care measure that can 
objectively quantify surgeon and other hospital system-related performance. The 
SCOUT score allowsthe surgeon to identify problem areas that can then be targeted for 
improvement to positively affect outcome. (J Vase Surg 1997;25:1007-15.) 
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Current criteria for evaluating surgical outcome 
are limited to raw mortality and morbidity rates. To 
date, the most sophisticated attempt o assess quality 
of surgical care is the National Veterans Administra- 
tion Surgical Risk Study) Although this study meets 
the important goal of providing comparative risk- 
adjusted mortality outcome data for various institu- 
tions, the study does not provide a morbidity index 
that incorporates a weighting system for each com- 
plication. In addition, there is no accounting for 
multiple complications associated with a single index 
procedure. 
As health care costs continue to escalate, there 
has been renewed interest by both health care pro- 
viders and receivers to evaluate the quality and cost- 
effectiveness of health care. In response to this inter- 
est, the Health Care Financing Administration 
(HCFA) and the Veterans Affairs hospitals have been 
releasing annual hospital mortality statistics after op- 
eration. 2,a The process was deemed "scorecard sur- 
gery" by the press when such data were made avail- 
able in New York and Pennsylvania for CABG 4,s and 
has been criticized for its lack of risk adjustment. 6 
Similarly, the performance of Health Maintenance 
Organizations (HMO) are currently being graded 
according to specifications set out in the Health Plan 
Employer Data and Information Set (HEDIS), 
whereas the Joint Commissions for the Accreditation 
ofHealthcare (JCAHO) established a similar process 
lmown as the Indicator Measurement System 
(IMS). 7,8 This system involves feedback to participat- 
ing institutions regarding their relative standing with 
respect o a number of performance measures, which 
include morbidity and mortality data. 
Prediction of mortality rates on the basis of dis- 
ease severity has been an area of great interest in both 
the medical and surgical literature. However, mor- 
bidity is almost universally ignored. Many scoring 
systems have been devised that are ideally suited to 
evaluate special types of surgical procedures or to 
assess a particular type of complication. Some scores 
are ideal for assessing the risk of death and, to a lesser 
extent, morbidity in particular groups of surgical 
patients, such as those with cardiovascular 9,1° or gas- 
trointestinal diseases, n 12 Others are useful in partic- 
ular surgical settings uch as the intensive care unit. 
One of the best-known and most widely used scoring 
systems is the Acute Physiologic and Chronic Health 
Evaluation (APACHE II), but it requires 24-hour 
observation and severity tables for individual disease 
states) 3Although such a score can be applied to a 
majority of surgical patients, it only assesses risk of 
death. 
The Society for Vascular Surgery and the Interna- 
tional Society for Cardiovascular Surgery, North 
American Chapter, have appointed an Ad Hoc Com- 
mittee to define standards of reporting outcome for a 
variety of vascular surgical procedures. 14-18 In addi- 
tion, in their two recent presidential addresses, Drs. 
Rutherford and Hertzer stress the importance of 
developing better methods of "outcome surveil- 
lance," which incorporates everity scoring and in- 
cludes all major complications. 19,2° Although such a 
method is useful for standardizing reporting of out- 
come data in the literature, the true benefit is to the 
individual surgeon and their patients. Any method 
that can objectively identify specific problems in sur- 
gical care that can then be targeted for focused im- 
provement will thereby improve outcome. It is in this 
spirit that the SCOUT score method has evolved. 
METHODS 
Development of  SCOUT method. A database 
of more than 9000 general and vascular surgical cases 
were compiled over a 3-year period at MetroWest 
Medical Center. Every postoperative complication 
ranging from tape rash to death was prospectively 
recorded by a surgical nurse on a daily basis. Compli- 
cation data were obtained from daily chart review or 
discussions with hospital staff. Nearly 100% capture 
was verified by the in-house quality assurance depart- 
ment, which routinely performs postdischarge chart 
review. 
Fifty clinically significant complications were se- 
lected out of a list of 151 complication types and 
were stratified into nine broad categories (vascular, 
cardiac, pulmonary, etc.) by a panel of practicing 
surgeons. The fifty complications used were selected 
specifically as they relate to vascular surgical patients. 
For example, shoulder pain attributable to pneumo- 
peritoneum after laproscopic surgery was omitted. In 
addition, complication types were selected to incor- 
porate all aspects of surgical care, including nursing 
and hospital system performance. For example, pres- 
sure ulcers are coded as "nursing specific," whereas 
wound infection and hematomas are "physician spe- 
cific." Incorrect preparation of medication dosages 
may be pharmacy or "hospital system" or nursing 
errors. 
For construction of the database, each complica- 
tion type (e.g., pneumothorax) was stratified into 
four severity grades (mild, moderate, severe, death). 
The grading system was only used to help orient the 
panel, who determined the SCOUT severity score 
for each complication. The panel of surgeons was 
asked to assign a SCOUT severity score for each 
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Table I. Examples of complication types, grading, and SCOUT severity scores 
Grade 
Complication type 1 (score) 2 (score) 3 (score) 4 (score) 
Pneumothorax Observe only 15 Chest ube 46 Thoracotomy 78 Death 100 
Pneumonia Mild symptoms 23 Intubation 66 Septic shock 88 Death 100 
Graft thrombosis Thrombectomy 50 Redo graft 76 Amputation 93 Death 100 
Colon ischemia Observe only 31 Sepsis/ICU 50 Colectomy 60 Death 100 
Abbreviated list ofcomplications and their assigned SCOUT scores. Scores were obtained by asking a panel of surgeons to assign a severity 
score based on the physiologic significance of the complication using a scale of 0 to 100. All SCOUT scores reflect he mean for the panel. 
Note that grade 1 complications can have severity scores higher than grade 2 complications. Death was automatically assigned a SCOUT 
score of 100 points. All SCOUT scores are stored in the program software and used for future prospective study. 
grade of complication using a range from 0 to 100 
(0, no complication; 100, death). The question 
posed to the panel was, "if this complication were to 
happen to you as a patient, how would you rate it in 
terms of physiologic stress"? This process was re- 
peated for all 50 complication types, grades 1 to 4. 
An example is shown in Table I. Grade 4 complica- 
tions (death) were automatically assigned a SCOUT 
score of 100 points. For example, agrade 1 pneumo- 
thorax requires observation only, a grade 2 pneumo- 
thorax would require a chest tube, a grade 3 pneu- 
mothorax would require surgery, and grade 4 
pneumothorax would result in death (Table I). The 
SCOUT severity score for each complication type 
reflects the mean score of the entire panel and was 
recorded in the database. Only the SCOUT score for 
each complication was recorded in the database and 
serves as a reference for scoring complications in 
future studies. 
Because complications vary in physiologic weight 
(for example, myocardial infarction is more severe 
than a wound infection), there were no preset guide- 
lines for each grade (such as grade 1 = 0 to 33; grade 
2 = 34 to 67). Thus several grade 1 complications 
may have higher SCOUT severity scores compared 
with some grade 2 complications (Table I). Patients 
were excluded from assigning SCOUT scores be- 
cause patients' perception of the severity of a compli- 
cation are often underestimated or overestimated. 
For example, many patients perceive thrombophlebi- 
tis of the arm as much more severe than asymptom- 
atic postoperative cardiac arrhythmias or electrocar- 
diogram changes. 
To ease data collection, a software program was 
designed to run on a laptop computer. The current 
database incorporates diagnosis and procedure cur- 
rent procedural terminology (CPT) code, patient 
medical history and risk factor data, pertinent labora- 
tory data, and the preassigned SCOUT severity 
scores. Clear and concise definitions of each compli- 
cation type and grade have been developed into a 
pocket manual to ensure standardized data collec- 
tion. When appropriate, complications were up- 
graded to different categories and recorded sepa- 
rately. For example, an apparent tape rash on 
postoperative day 1 that develops into cellulitis is 
recorded as such separately. Such a system may 
slightly overestimate morbidity rates, but the goal 
was to capture all postoperative events. 
Collected data are downloaded into the depart- 
ment's database for statistical analysis. Output data 
can be formatted to analyze individual patients, sur- 
geons, or case types, or institution performance as a 
whole. For comparison, the optimal SCOUT score is 
0 points. Because the SCOUT score is a running 
total throughout the in-hospital postoperative pe- 
riod, there is no upper limit. Each broad category is
system-specific (vascular, cardiac, etc.), allowing 
problem areas to be more easily identified. 
Patient outcome and SCOUT score. Over the 
past 12 months, 170 patients who underwent major 
vascular procedures (abdominal aneurysm repair 
[AAA], carotid endarterectomy [CEA], femoropop- 
liteal bypass grafting, and femoral infrageniculate by- 
pass grafting) were studied prospectively using the 
SCOUT score method. Preoperative data, including 
age, sex, medical and surgical history, vascular dis- 
ease risk factors, laboratory data, and preoperative 
diagnosis, were entered into an individual database 
for each patient before surgery. After surgery, the 
procedure performed was entered into the database 
using standard CPT code definitions. During each 
day of hospitalization, a surgical nurse would per- 
form prospective chart review and meet with nursing 
staff and residents to monitor the progress of the 
patient. Any complication that met the criteria out- 
lined in the complication definition manual was re- 
corded in the database and automatically assigned 
the appropriate SCOUT score for the complication. 
A running total for the in-hospital SCOUT score is 
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Table II. Patient demographics 
Mean age 70.6 + 9.0 yr 
History of CAD 46.2% 
History of HTN 56.9% 
History of DM 20.6% 
Male 62.5% 
Female 37.5% 
CAD, Coronary artery disease; HTN, hypertension; DM, diabetes 
mellitus. 
displayed for convenience. Graphically displayed out- 
put reports focusing on the entire department, indi- 
vidual surgeon, procedure, or complication type are 
easily obtained. 
Statistical analysis. All data are presented as 
mean + standard error of the mean. Statistical signif- 
icance was tested separately using analysis ofvatiance 
using a statistical software package. Intergroup com- 
parisons were made using Student's t test when the 
overall analysis of variance was significant (p < 0.0 5). 
RESULTS 
Examples of complication type, grade, and 
SCOUT severity score are shown in Table I. Notice 
that the SCOUT scores generally reflect he physio- 
logic significance of each complication as reported by 
the panel of surgeons. Thus "mild" or grade i com- 
plications can have SCOUT scores significantly 
higher than "severe" grade 3 complications depend- 
ing on the type of complication encountered. 
The demographic data of the 170 vascular pa- 
tients are shown in Table II. The mean age was 70.6 
years, with 62.5% of the patients being male. Risk 
factor stratification was typical of a urban community 
hospital vascular practice, with 20.6% of the patients 
having a history of diabetes, 56.9% having hyperten- 
sion, and 46.2% having documented cardiac disease. 
Table III shows the total list of the 50 clinically 
significant complication types and the nine broad 
system categories. Although the majority of the com- 
plications focus on surgical performance, several 
nursing- and hospital system-specific complications 
were also included. 
In-hospital morbidity and 30-day mortality rates, 
as well as a breakdown of the complication severity 
grades, is shown in Table IV. Morbidity rates were 
calculated from the number of patients who had at 
least one complication divided by the total number 
of procedures of that type. Overall, 116 complica- 
tions were captured in the 170 patients. The overall 
morbidity rate was 51.2%; 83 patients had no com- 
plications. 
Of the 35 AAA repairs, 24 patients had a total of 
Table III. System categories and 
complication types followed with SCOUT 
Category Complication 
Vascular Graft thrombosis 
Graft infection 
Unexpected tissue loss/amputation 
Colon ischemia 
Spinal cord ischemia 
Compartment syndrome 
Deep venous thrombosis (confirmed) 
Neurologic 
Cardiac 
Pulmonary 
Urinary tract 
Wound 
Hematologic 
Gastrointestinal 
General 
Thrombophlebitis 
Embolism 
Stroke 
Nerve injury 
Transient ischemic attack 
Mental status changes 
Hypotension/shock 
Arrhythmia 
Cardiac arrest 
Congestive heart failure 
Myocardial ischemia/infarct 
Pneumothorax 
ARDS 
Pneumonia 
Pulmonary embolism (confirmed) 
Aspiration pneumonia 
Prolonged ventilation (>24 hr) 
Obstruction/retention 
Urinary infection 
Renal failure 
Other (leak, urinoma) 
Pressure ulcer 
Wound hematoma 
Wound infection 
Surgical bleeding 
DIC 
Bowel obstruction 
Ileus 
Perforation 
Fistula 
Pancreatitis 
GI bleeding 
Diarthea/infectious 
Bile duct injury 
Anastomotic leak 
Injury to adjacent structure 
Intraabdominal bscess 
Bacteremia 
Drug reaction 
Fever 
Nausea/vomiting 
Error in diagnosis 
Delay in diagnosis 
ARDS, Adult respiratory distress syndrome; DIC, disseminated 
intravascular coagulation; GI, gastrointestinal. 
43 complications, with an overall morbidity rate of 
68%. Eleven patients who underwent AAA repair had 
no complications. Thirty-two complications were 
identified in 26 paticnts who underwent CEA. Forty- 
four paticnts who underwent CEA had no complica- 
tions. Patients who underwent below-knce femoro- 
popliteal bypass grafting had a morbidity rate of 60%, 
with 20 patients experiencing no complications. 
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Fig. 1. Mean SCOUT scores by case and complication system category. G/, Gastrointestinal; 
neur, neurologic; vase, vascular; hemato, hematologic; urin, urinary tract; pulm, pulmonary. 
Fern-distal, femorodistal bypass grafting; fer -pop, femoropopliteal bypass grafting. 
Table IV. Morbidity and mortality rates and complications by grade 
Case type n Events (grade 1,2,3,4) Morbidity rate (N1) Mortality rate 
AAA 35 43 (21, 19, 0, 3) 68% (24) 8.6%* 
CEA 70 32 (18, 13, 1, 0) 37% (26) 0.0% 
POP 50 30 (16, 14, 0, 0) 60% (30) 0.0% 
DISTAL 15 11 (8, 3, 0, 0) 46% (7) 0.0% 
Total 170 116 (62, 49, 1, 3) 51% (87) 1.8% 
N1, Number of patients with at least one complication; POP, femoropopliteal bypass grafting; DISTAL, femorodistal bypass grafting. 
*Includes two ruptured AA_As. 
Four acute graft failures were identified, for an over- 
all patency rate of 80% at 12 months. Three of the 
graft failures were associated with the use ofpolytet- 
rafluoroethylene graft material. Femorodistal bypass 
procedures had an overall complication rate of 46%, 
with eight patients having no complications. No 
graft failures were observed uring the study period 
in this group. All of the grafts were constructed with 
in situ saphenous vein. 
The stratification of mean SCOUT scores for 
each case type and complication category is shown in 
Fig. 1. AAA repair was associated with the highest 
morbidity rate, with a mean SCOUT score of 
384.35, and distal bypass procedures had the lowest 
morbidity rate (mean SCOUT score, 114.4). Fig. 2 
shows the percent of total morbidity stratified by 
each system category. As expected, the majority of 
the morbidity was observed in the cardiac category 
with the exception of femoropopliteal bypass proce- 
dures, which had more vascular complications. Sub- 
group analysis demonstrated that this finding was 
related to the large severity score associated with four 
acute graft failures. Three of these bypass grafts were 
constructed with polytetrafluoroethylene and re- 
quired either thrombectomy or revision. There were 
no distal bypass graft failures at I year. 
Interestingly, there was a relatively high cardiac 
morbidity rate observed in patients who underwent 
infrageniculate bypass procedures that accounted for 
52% of the overall morbidity (Fig. 2). This incidence 
was significantly higher than the cardiac morbidity 
rate observed after AAA repair (52% vs 34.7%; p < 
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Fig. 2. Percent morbidity for each case type stratified by complication type. Abbreviations are 
same as in Fig. 1. 
0.05) or femoropopliteal bypass procedures (52% vs 
21%; p < 0.05). 
Urinary complications observed in patients who 
underwent CEA were associated with Foley catheter 
insertion. Patients who avoided Foley catheter inser- 
tion had no urinary complications. 
DISCUSSION 
Attempts to evaluate "quality of surgical care" 
have been difficult. It is clear that raw morbidity and 
mortality rates do not necessarily equate with quality 
of care. We are all aware of practitioners who have 
acceptable or even excellent mortality rates, but 
whose patients experience xcessive morbidity, in- 
creased hospital stay and costs, and lose significant 
functional status after discharge. Conversely, we may 
have watched in desperation when a perfect opera- 
tion has been mined by inadvertent ursing or "hos- 
pital-system" errors. Clearly, there is a need to de- 
velop methods that incorporate all aspects of the 
continuum of surgical care and not simply focus on 
surgical performance. 
One of the most sophisticated and elegant at- 
tempts to fairly evaluate surgical care and outcome is 
the Veterans Administration Surgical Risk Study.1 As 
has been the case with many hospital systems, the 
Veterans Administration is experiencing pressure to 
decrease the number of its hospitals as a result of 
increasing hospital costs in the face of a decreasing 
veteran patient pool. To establish coherent guide- 
lines for hospital consofidation, the study group pro- 
spectively established a database of more than 
250,000 major surgical cases and developed risk- 
adjusted models of expected outcome determined by 
a number of preoperative comorbidities (Dr. Khuri, 
personal communication, July, 1996). With very so- 
phisticated mathematical modeling, accurate calcula- 
tion of expected mortality rate for any index case can 
be determined. This is then compared with e ob- 
served mortality rate using the observed to expected 
(O/E) ratio. Hospitals with O/E  ratios greater than 
i have mortality rates that are higher than predicted. 
Similarly, hospitals with O/E  ratios lower than i 
have lower mortality rates than expected. Using this 
format, "outlier" institutions are easier to identify 
even if their raw mortality rate is acceptable as a result 
of very low acuity. 
The comparison of vascular surgeons has gener- 
ally involved the analysis of broad measures such as 
mortality and morbidity rates, graft patency rates, 
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amputation rates, and readmission rates. Growing 
importance and weight have been given to new mea- 
sures including length of stay and hospital cost or 
"resource utilization." These data are rarely adjusted 
for the patient's everity of illness, thus practitioners 
or hospitals can cite increased isease acuity as a 
means to explain excessive morbidity or mortality 
rates. Fearing selective contracting or adjustments in 
reimbursement, the incentive for "outlier" providers 
may be to avoid treating high-risk patients or to 
inappropriately up-code the level ofcomorbid condi- 
tions. Therefore, fair and accurate methods for mea- 
suring health care outcome need to be devised. 
One recent attempt to evaluate "quality of surgi- 
cal care" has been the development of the Physio- 
logic and Operative Severity Score for the enUmera- 
tion of Mortality and Morbidity (POSSUM). 21 This 
system scores patients before surgery on the basis of 
comorbidities, during surgery on the basis of surgical 
performance, and after surgery on the basis of com- 
plications. Although the system has some utility in 
predicting death, it suffers from an arbitrary scoring 
scale and lack of true risk-adjustment. 
The importance of risk-adjustment to fairly eval- 
uate quality of surgical care has not always been 
appreciated. 22,23 Patient factors such as personality, 
religious beliefs, and motivation may have a pro- 
found effect on outcome. Because these parameters 
are intangible, they cannot be readily measured. 
Therefore, some opponents to outcome research ar- 
gue that because we can never hope to measure all 
relevant risk factors, complication rate comparisons 
are inappropriate and the reporting of "risk-adjust- 
ed" statistics hould be abandoned. Such concerns 
may be warranted if the sole purpose of comparative 
studies is to stigmatize and penalize providers or 
institutions with poorer outcome without proposing 
solutions to improve outcome. 
The SCOUT score was developed as a tool for 
the surgeon to identify problem areas in surgical care. 
By stratifying outcome into broad categories, it 
should be easier to identify surgeon, nursing, and 
hospital-system problems. For example, in this study 
the cardiac morbidity rate was significantly higher in 
patients who underwent distal bypass procedures 
compared with femoropopliteal bypass grafting or 
AAA repair. Review of our femorodistal bypass pro- 
cedures demonstrated that invasive monitoring with 
arterial and pulmonary arterial catheters was used 
significantly ess than with the other case types. This 
observation is made despite the fact that peripheral 
vascular surgery is associated with greater cardiac 
morbidity rates and overall mortality rates than other 
forms of noncardiac surgery. 2<2s It is unclear 
whether more extensive perioperative cardiac moni- 
toring would have decreased cardiac morbidity rates, 
but there is a growing body of evidence that argues 
for routine use ofinvasive perioperative cardiac mon- 
itoring and intravenous nitroglycerin patients who 
undergo peripheral vascular surgeryfl 6 We have 
changed our practice to address this point. 
In this study, more than half of the complications 
were mild and required observation or minimal treat- 
ment. Because an extensive complication list is rou- 
tinely followed, the reported morbidity rates in this 
study are generally higher than reported in the liter- 
ature. However, the observed mortality rate of 1.8% 
is similar to other large series) 6 Therefore, the 
higher morbidity rates observed in this study proba- 
bly reflect improved capture of postoperative events 
and not worse outcome. 
For fair scoring and assessment across institu- 
tions, risk-adjustment methods need to be developed 
and routinely used. These may be as complicated as 
the Veterans Administration method or as simple as 
stratifying by American Society of Anesthesiologists 
classification. ~ Further studies are needed to test the 
SCOUT method in a variety clinical settings while 
using a variety of risk-adjustment parameters. 
The SCOUT score is a technical quality of care 
measure that is complimentary to other currently 
available mortality and morbidity outcome measures. 
With a standardized weighting system for commonly 
observed postoperative complications for any index 
case, coherent analysis of surgical practice can be 
made. 
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DISCUSSION 
Dr. Gary Gibbons (Boston, Mass.). I think this is a 
great beginning on something that, whether we like it or 
not, we need to be involved with. I would invite everyone 
to be proactive in this because as we have learned, it is 
better that we work to improve physician-driven outcome 
measures than having someone with no knowledge of what 
we do doing it for us. Where physicians have not gotten 
involved, outcome analysis is being done by insurers or 
nonphysician groups. I think we can take advantage of the 
Northern New England cardiac database experience. If we 
can look at ourselves in a nonthreatening way, we can all 
make care better for our patients. 
I have a couple of questions. You're looldng at in- 
hospital data. Is it possible to include patient satisfaction 
with this, because we're all being required to include pa- 
tient-reported outcome? Second, can we validate this, not 
only in a community hospital, but take it to an academic 
setting? Is there adaptability here that we can really take 
across a network? Third, although it may seem to everyone 
that this represents a lot of complications, I think the thing 
that we have learned in doing physician report cards and 
looking through the record is that we really underestimate 
the degree of complications. I mean, most people don't 
record Clostridium cliff,tile infection as a complication, and 
it has enormous impact not only in the quality of the 
outcome but also on the cost. 
Dr. James J. PomposeUi. Satisfaction surveys can be 
added to the method without difficulty, and we have dis- 
cussed the importance of including these surveys. We be- 
lieve the method is valid and adaptable to both community 
hospitals and academic enters, although our original in- 
tent was to track and improve outcome at our own institu- 
tion. Because we report all postoperative events, our com- 
plication rate is considerably higher than has been reported 
in previous studies. We agree that overall complication 
rates tend to be underestimated in the literature. 
Dr. Jack L. Cronenwett (Lebanon, N.H.). I think 
that this method is a great step forward. 
I have two questions. First, have you found a way to 
incorporate subsequent outcomes, that is, outpatient re- 
sults into your database? Second, when you compared 
severity scores assigned by different physicians, how much 
variation was there? Have you begun to ask patients to 
assign severity to these complications yet? 
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Dr. J. Pomposelli. The logistics of collecting outpa- 
tient data is more difficult than collecting inpatient data. 
This is because we have to depend on the surgeon being 
honest o report a delayed complication. The question is 
whether such reporting should be mandated. We believe 
that it should be. We have specifically not asked patients for 
severity scores because we believe that patients' medical 
knowledge base is not sophisticated nough to understand 
the relative impact of each complication. 
Dr. Frank B. Pomposell i  (Boston, Mass.). It seems to 
me that the key thing in your scoring system is the severity 
score that was assigned by your panel of surgeons. Has 
there been some attempt to validate this method of assign- 
ing severity to avoid institutional or local biases in percep- 
tion? 
Dr. J. Pomposelli. You are correct. Our scoring sys- 
tem was based on our own group of local practitioners. We 
are planning to reassign the severity scores with a much 
larger panel of practitioners from several different institu- 
tions and specialties. Hopefully this will average out re- 
gional or specialty biases. 
Dr. Edward M. Kwasnik (Westbury, Conn.). I am 
very impressed by your efforts and have two quick ques- 
tions. First, who has access to these data? Are there any 
safeguards in place to prevent hem from being in the 
public domain? And second, was this a consecutive series 
of all vascular cases during that time period? 
Dr. J. Pomposelli. The data is not currently available 
for public disclosure. The study was conducted on consec- 
utive patients over a 3-year period. 
Dr. Kwasnik. From a legal point of view, is this infor- 
mation "discoverable," or is it protected under peer review 
in your current situation? 
Dr. Sushi/K. Gupta. It is protected under peer eview 
now because we made it an instrument of the quality care 
department, soit's under peer review. 
